| Issue Date | Title | Author(s) | Type | scopus | WOS | Fulltext/Archive link |
| 2001 | Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen | Hung C.-F.; WEN-FANG CHENG ; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. | journal article | 0 | | |
| 2002 | Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion | WEN-FANG CHENG ; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. | journal article | 111 | 101 | |
| 2005 | Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis | WEN-FANG CHENG ; Hung C.-F.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C. | journal article | 26 | 24 | |
| 2005 | Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis | Cheng W.-F.; Hung C.-F.; CHI-AN CHEN ; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C. | journal article | 26 | 24 | |
| 2001 | Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand | Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG ; Chai C.-Y.; He L.; Ling M.; Wu T.-C. | journal article | 0 | | |
| 2001 | Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | journal article | 72 | 59 | |
| 2001 | Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C. | journal article | 62 | 55 | |
| 2001 | Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments | WEN-FANG CHENG ; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C. | journal article | 61 | 55 | |
| 2001 | Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen | Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG ; He L.; Slater L.A.; Ling M.; Wu T.-C. | journal article | 106 | 89 | |
| 2003 | Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes | Hung C.-F.; WEN-FANG CHENG ; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C. | journal article | 0 | | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. | journal article | 16 | 16 | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | Cheng W.-F.; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN ; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. | journal article | 16 | 16 | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; WEN-YIH TSENG ; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. | Journal Article | 16 | 16 | |
| 2001 | Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen | Hung C.-F.; WEN-FANG CHENG ; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | journal article | 127 | 111 | |
| 2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; MING-CHIH HO ; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | journal article | 22 | 20 | |
| 2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group | journal article | 22 | 23 | |
| 2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Chiun Hsu ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group | journal article | 22 | 23 | |
| 2004 | Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways | WEN-FANG CHENG ; Hung C.-F.; Lee C.-N.; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; Chen C.-A.; Hsieh C.-Y. | journal article | 15 | 14 | |
| 2004 | Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways | Cheng W.-F.; Hung C.-F.; Lee C.-N.; Su Y.-N.; Chang M.-C.; He L.; Wu T.-C.; CHI-AN CHEN ; Hsieh C.-Y. | journal article | 15 | 14 | |
| 2005 | A nationwide survey on epidemiological characteristics of childhood Henoch-Sch?nlein purpura in Taiwan | Yang Y.-H.; Hung C.-F.; Hsu C.-R.; Wang L.-C.; Chuang Y.-H.; Lin Y.-T.; BOR-LUEN CHIANG | Journal Article | 107 | 97 | |
